Works matching IS 00070963 AND DT 2016 AND VI 175 AND IP 2


Results: 48
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the Bio CAPTURE registry

    Published in:
    British Journal of Dermatology, 2016, v. 175, n. 2, p. 340, doi. 10.1111/bjd.14552
    By:
    • Zweegers, J.;
    • Reek, J.M.P.A.;
    • Kerkhof, P.C.M.;
    • Otero, M.E.;
    • Kuijpers, A.L.A.;
    • Koetsier, M.I.A.;
    • Arnold, W.P.;
    • Berends, M.A.M.;
    • Weppner ‐ Parren, L.;
    • Ossenkoppele, P.M.;
    • Njoo, M.D.;
    • Mommers, J.M.;
    • Lümig, P.P.M.;
    • Driessen, R.J.B.;
    • Kievit, W.;
    • Jong, E.M.G.J.
    Publication type:
    Article
    31
    32
    33
    34
    35
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    News and Notices.

    Published in:
    British Journal of Dermatology, 2016, v. 175, n. 2, p. 436, doi. 10.1111/bjd.14893
    Publication type:
    Article
    47

    Plain language summaries.

    Published in:
    British Journal of Dermatology, 2016, v. 175, n. 2, p. e103, doi. 10.1111/bjd.14894
    Publication type:
    Article
    48